Skip to main content

News Archive

News Archive - Yadira Galindo

Repurposed Asthma Drug Shows Blood Sugar Improvement among Some Diabetics

July 5, 2017

After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.

UC San Diego Partners with Janssen to Research New Approaches to Treat Metabolic Diseases

June 15, 2017

University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.

Review of Appendix Cancer Cases Finds Over Diagnosis

June 7, 2017

Lesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper published June 7 in the journal PLOS ONE.

National Study Looks at Tobacco Advertising and Susceptibility to Use Tobacco Among Youth

May 21, 2017

Among 12- to 17-year-olds who have never used tobacco products, nearly half were considered receptive to tobacco marketing if they were able to recall or liked at least one advertisement, report researchers at University of California San Diego Moores Cancer Center and Dartmouth’s Norris Cotton Cancer Center, in a new national study. Receptivity to tobacco ads is associated with an increased susceptibility to smoking cigarettes in the future.

Pathways Leading to Beta Cell Division Identified, May Aid Diabetes Treatment

May 2, 2017

Pancreatic beta cells help maintain normal blood glucose levels by producing the hormone insulin — the master regulator of energy (glucose). Impairment and the loss of beta cells interrupts insulin production, leading to type 1 and 2 diabetes. Using single-cell RNA sequencing, researchers at University of California San Diego School of Medicine have, for the first time, mapped out pathways that regulate beta cell growth that could be exploited to trick them to regenerate.

Students Propose Solutions to Critical Health Issues at Annual Hackathon

March 23, 2017

From virtual reality to crowdsourcing ideas, participants at UC Health Hack 2017 combined creativity and problem-solving to create projects addressing critical issues in health systems and global health. The 181 participants focused on one of two tracks: health care delivery or refugee health.

Transplanting Good Bacteria to Kill Staph

February 22, 2017

University of California San Diego School of Medicine researchers screened 10,000 colonies of bacteria found on the epidermis to determine how many had antimicrobial properties and at what rate these are found on healthy and non-healthy skin. In a paper published in Science Translation Medicine, the team reports isolating and growing good bacteria that produce antimicrobial peptides and successfully transplanting it to treat patients with the most common type of eczema, known as atopic dermatitis.

Analyzing Copies of Genes Offers New Treatment Possibilities for Ovarian Cancer

February 15, 2017

A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.

UC San Diego Health Prioritizes Patient Experience with iPad and Apple TV

December 6, 2016

Patients at the newly opened Jacobs Medical Center at UC San Diego Health can be in command of their own experience by controlling room temperature, lighting, accessing their personal medical information, details on their patient care team and entertainment options all from their beds.

Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity

December 1, 2016

Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.
Category navigation with Social links